Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shanghai
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Beijing Tiantan Biological Products Corp Ltd

+ Add to Watchlist

600161:CH

30.710 CNY 0.870 2.75%

As of 02:05:43 ET on 03/06/2015.

Snapshot for Beijing Tiantan Biological Products Corp Ltd (600161)

Open: 31.650 Day's Range: 30.510 - 31.660 Volume: 7,642,609
Previous Close: 31.580 52wk Range: 16.590 - 33.000 1-Yr Rtn: +59.04%

Stock Chart for 600161

No chart data available.
  • 600161:CH 30.700
  • 1D
  • 1M
  • 1Y
31.580
Interactive 600161 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 600161

Current P/E Ratio (ttm) 55.0747
Estimated P/E(12/2014) 40.9467
Relative P/E vs. SHASHR 3.5177
Earnings Per Share (CNY) (ttm) 0.5576
Est. EPS (CNY) (12/2014) 0.7500
Est. PEG Ratio -
Market Cap (M CNY) 15,829.99
Shares Outstanding (M) 515.47
30 Day Average Volume 8,549,454
Price/Book (mrq) 7.3809
Price/Sale (ttm) 7.8794
Dividend Indicated Gross Yield -%
Cash Dividend (CNY) 0.1000
Dividend Ex-Date 07/19/2012
5 Year Dividend Growth -
Next Earnings Announcement 03/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 600161

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 600161

Beijing Tiantan Biological Products Corporation Limited researches, develops, and commercializes biological products. The Company provides treatment for hepatitis and offers a line of vaccine products including hepatitis vaccines and rubella vaccines.

Zeng LingbingPresidentYang XiaobingVice President
Wu ZhenshanVice PresidentZheng XiaoliVice President
More Company Profile & Key Executives for 600161

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil